Cannabinoids in chronic non-cancer pain medicine: moving from the bench to the bedside.

Published by Michael on

Related Posts

Medical

Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/beta-catenin pathway

Mol Psychiatry. 2021 Apr 9. doi: 10.1038/s41380-021-01086-1. Online ahead of print. ABSTRACT Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder characterized by recurrent and distinctive obsessions and/or compulsions. The etiologies remain unclear. Recent findings have shown Read more…

Medical

Case of e-cigarette or vaping product use-associated lung injury (EVALI) in London, UK

BMJ Case Rep. 2021 Apr 9;14(4):e240700. doi: 10.1136/bcr-2020-240700. ABSTRACT We present a case of a 38-year-old man with no medical comorbidities who presented to the hospital with haemoptysis and shortness of breath on a background Read more…

Medical

Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank

Transl Psychiatry. 2021 Apr 9;11(1):211. doi: 10.1038/s41398-021-01330-w. ABSTRACT Cannabis is known to produce acute, transient psychotic-like experiences. However, it is unclear whether cannabis disproportionately increases the risk of specific types of psychotic experiences and whether Read more…

error: Content is protected !!